Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopropofol vs propofol for AKI after robotic partial nephrectomy
ChiCTR2600119086Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Feb 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in renal mass comparing Cyclopropofol group with Propofol group (2 arms). Primary endpoint: Incidence of postoperative acute kidney injury. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
renal mass
Beyond the preview
Go deeper on ChiCTR2600119086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119086.